'Mock' Recalls Suggested, But US FDA Isn't Joking About Recalling Products
Executive Summary
FDA's suggestions in voluntary recalls draft guidance largely track with advice attorneys long have offered consumer health product firms. Instead, on top of November guidance on mandatory recall authority and February guidance on recall public notifications, FDA is making clear its expectations for firms' preparedness for recalls and their responses when faced with removing products from store shelves.
You may also be interested in...
US FDA's Expectations And Firms’ Responsibilities Clarified In Voluntary Recalls Final Guidance
Final guidance describes in greater detail than draft published in 2019 the agency’s expectations for marketers and other businesses’ responses when they need to recall FDA-regulated products.
Support To Grant US FDA Authority To Order Recalls Of All Drugs Grows With Bill Introduced In Senate
Sen. Gary Peters says FDA should have the authority because relying on drug marketers to voluntarily recall products the agency has deemed unsafe isn’t sufficient to protect public health. He notes that manufacturers of OTC hand sanitizers imported from Mexico and found to contain methanol haven’t cooperated with the FDA on recalling the products.
Expanding US FDA Mandatory Recall Authority To All Drugs Gets House Appropriators’ Approval
Appropriators’ FDA FY 2021 budget includes amendment to expand its mandatory recall authority introduced by chairman of subcommittee with oversight of agency’s budget, Rep. Sanford Bishop. He said the agency should be able to force drug product recalls as it already can for vaccines, medical devices and products containing ingredients also scheduled as controlled substances.